Home

LifeMD, Inc. - Common Stock (LFMD)

5.5550
-0.1850 (-3.22%)

Lifemd Inc is a biotechnology company focused on advancing personalized medicine by leveraging cutting-edge technology and data analytics to develop innovative diagnostic solutions and therapeutics

Their mission centers around improving patient outcomes through tailored healthcare approaches, harnessing the power of genetic information and biomarkers to better understand individual health traits and disease predispositions. By aiming to provide precise treatment options, Lifemd Inc is dedicated to transforming the landscape of healthcare and empowering patients with actionable insights for managing their health.

SummaryNewsPress ReleasesChartHistoricalFAQ
Previous Close5.740
Open5.740
Bid5.550
Ask5.560
Day's Range5.455 - 6.030
52 Week Range3.990 - 12.88
Volume677,973
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume506,643

News & Press Releases

Can the New CEO Revive This Struggling Telehealth Stock?
Virtual healthcare provider Teladoc Health Inc. (NYSETDOC) stock is trading down 57.8% year-to-date (YTD). The collapse occurred after reporting Q4 2023
Via MarketBeat · July 24, 2024
3 Overlooked Telehealth Stocks Poised for a Comebackinvestorplace.com
Telehealth stocks are on the rise as firms expand virtual healthcare services, boosting patient outcomes and engagement.
Via InvestorPlace · July 16, 2024
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · June 10, 2024
10 Health Care Stocks Whale Activity In Today's Sessionbenzinga.com
Via Benzinga · June 4, 2024
Recap: LifeMD Q4 Earningsbenzinga.com
Via Benzinga · March 11, 2024
Earnings Outlook For LifeMDbenzinga.com
Via Benzinga · March 8, 2024
$100 Invested In LifeMD 5 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · January 19, 2024
Hims & Hers Health Soars on Generic GLP-1 Rollout Plans
Him & Hers Health Inc. (NYSEHIMS) provides a direct-to-consumer (DTC) health and wellness platform. The company was best known for prescribing treatments
Via MarketBeat · June 3, 2024
LifeMD Can Surge on Its GLP-1 Offerings
LifeMD is a leading telehealth provider that investors should take note of; the company is entering the GLP-1 market, and its stock could soar as a result
Via MarketBeat · May 28, 2024
Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Duolingo And Other Big Stocks Moving Lower In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · May 9, 2024
Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Sessionbenzinga.com
Via Benzinga · May 9, 2024
LFMD Stock Earnings: LifeMD Beats EPS, Beats Revenue for Q1 2024investorplace.com
LFMD stock results show that LifeMD beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 8, 2024
Inspire Medical Systems Stock Sees IBD RS Rating Rise To 78investors.com
On Tuesday, Inspire Medical Systems stock earned an upgrade to its Relative Strength (RS) Rating, from 69 to 78.
Via Investor's Business Daily · April 30, 2024
Dexcom Stock Continues To Post Very Healthy Profits, Returnsinvestors.com
Dexcom earns a lofty No. 5 rank among its peers in the 130-stock Medical-Products industry group. It got a rating upgrade Tuesday.
Via Investor's Business Daily · April 30, 2024
Staar Surgical Stock Climbs The Leadership Ladder With Jump To 84 RS Ratinginvestors.com
On Thursday, implantable lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 84, up from 80 a day earlier.
Via Investor's Business Daily · April 25, 2024
Dexcom Stock Shows Market Leadership, Gets Rating Upgrade. Prognosis Good.dexcom
Among its other key ratings Dexcom has a near-best 98 Earnings Per Share Rating out of 99, reflecting strong profit growth this past year.
Via Investor's Business Daily · March 26, 2024
Edwards Lifesciences Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmarkinvestors.com
The Relative Strength (RS) Rating for Edwards Lifesciences stock jumped into a new percentile Tuesday, with a rise from 78 to 81.
Via Investor's Business Daily · March 19, 2024
LifeMD Shares Come Back to Life on GLP-1 Business Growth
LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024
Via MarketBeat · March 19, 2024
DexCom Stock Trying To Close In On Key Technical Benchmarkdexcom
In a welcome move, medical device DexCom stock saw its Relative Strength Rating improve from 68 to 73 on Monday.
Via Investor's Business Daily · March 18, 2024
3 Stocks That Could Benefit from the Rise of Telemedicineinvestorplace.com
With growing demand, the market for telemedicine stocks could be worth about $450 billion by the time 2032 rolls around.
Via InvestorPlace · March 14, 2024
Can WeightWatchers Regain its Mojo after Oprah Steps Down?
WW International Inc. (NASDAQWW) (WeightWatchers) has had a disastrous 2024, with its shares collapsing 66.7% year-to-date (YTD).
Via MarketBeat · March 13, 2024
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · March 11, 2024
Earnings Scheduled For March 11, 2024benzinga.com
Companies Reporting Before The Bell • Ballard Power Systems (NASDAQBLDP) is estimated to report quarterly loss at $0.13 per share on revenue of $34.20 million.
Via Benzinga · March 11, 2024
Hey, Bottom Fishers! 3 Beaten Up Stocks to Buy for Short-Term Gainsinvestorplace.com
These three companies are beaten up stocks to buy, as their oversold status and solid fundamentals make them attractive picks.
Via InvestorPlace · March 7, 2024
Hims & Hers Stock Rises On Stimulating Earnings Growth
Telehealth platform Hims & Hers has turned the corner into GAAP profitability and is expanding its product portfolio to increase its addressable audience
Via MarketBeat · March 5, 2024